Glycomic analyses of glycoproteins in bile and serum during rat hepatocarcinogenesis
- PMID: 20731380
- DOI: 10.1021/pr100414r
Glycomic analyses of glycoproteins in bile and serum during rat hepatocarcinogenesis
Abstract
Fucosylated alpha-fetoprotein (AFP) is a specific tumor marker for hepatocellular carcinomas (HCC). However, the mechanisms underlying the increase in fucosylated AFP in serum of patients with HCC are largely unknown. Recently, we reported that fucosylation is a possible signal for the secretion of glycoproteins into bile in the liver. This finding might lead to the selective secretion of fucosylated AFP into bile and the selective secretion might be disrupted in hepatocarcinogenesis. In this study, therefore, we analyzed the oligosaccharide structures of glycoproteins in bile and serum of LEC rats, which are a rat model of spontaneous hepatocarcinogenesis. Lectin microarraying showed enhanced binding of 13 lectins to bile, compared with in serum from normal LEC rats, and the binding of these lectins to serum of LEC rats bearing HCC was higher than in normal rats. Structural analyses involving HPLC and mass spectrometry showed that the fucosylation levels of serum glycoproteins were not increased in CH rats but were in HCC rats, although the fucosylation levels of biliary glycoproteins were increased in both CH and HCC rats. These results suggested that the sorting machinery through fucosylation might be disrupted in the liver with HCC.
Similar articles
-
Analysis of polarized secretion of fucosylated alpha-fetoprotein in HepG2 cells.J Proteome Res. 2012 May 4;11(5):2798-806. doi: 10.1021/pr201154k. Epub 2012 Apr 17. J Proteome Res. 2012. PMID: 22483194
-
Fucosylation of N-glycans regulates the secretion of hepatic glycoproteins into bile ducts.J Biol Chem. 2006 Oct 6;281(40):29797-806. doi: 10.1074/jbc.M605697200. Epub 2006 Aug 9. J Biol Chem. 2006. PMID: 16899455
-
Sugar chains of human cord serum alpha-fetoprotein: characteristics of N-linked sugar chains of glycoproteins produced in human liver and hepatocellular carcinomas.Cancer Res. 1993 Jul 1;53(13):2970-5. Cancer Res. 1993. PMID: 7686446
-
A strategy for discovery of cancer glyco-biomarkers in serum using newly developed technologies for glycoproteomics.FEBS J. 2010 Jan;277(1):95-105. doi: 10.1111/j.1742-4658.2009.07430.x. Epub 2009 Nov 17. FEBS J. 2010. PMID: 19919546 Review.
-
Natural history of hepatocellular carcinoma as viewed by the pathologist.Appl Pathol. 1988;6(2):105-16. Appl Pathol. 1988. PMID: 2839213 Review.
Cited by
-
Development of recombinant Aleuria aurantia lectins with altered binding specificities to fucosylated glycans.Biochem Biophys Res Commun. 2011 Oct 14;414(1):84-9. doi: 10.1016/j.bbrc.2011.09.027. Epub 2011 Sep 14. Biochem Biophys Res Commun. 2011. PMID: 21945439 Free PMC article.
-
In vivo modulation of iNOS pathway in hepatocellular carcinoma by Nigella sativa.Environ Health Prev Med. 2013 Sep;18(5):377-85. doi: 10.1007/s12199-013-0336-8. Epub 2013 Apr 23. Environ Health Prev Med. 2013. PMID: 23609474 Free PMC article.
-
Capitalizing glycomic changes for improved biomarker-based cancer diagnostics.Explor Target Antitumor Ther. 2023;4(3):366-395. doi: 10.37349/etat.2023.00140. Epub 2023 Jun 28. Explor Target Antitumor Ther. 2023. PMID: 37455827 Free PMC article. Review.
-
New Enzymatic Approach to Distinguish Fucosylation Isomers of N-Linked Glycans in Tissues Using MALDI Imaging Mass Spectrometry.J Proteome Res. 2020 Aug 7;19(8):2989-2996. doi: 10.1021/acs.jproteome.0c00024. Epub 2020 Jun 8. J Proteome Res. 2020. PMID: 32441096 Free PMC article.
-
Discrimination between adenocarcinoma and normal pancreatic ductal fluid by proteomic and glycomic analysis.J Proteome Res. 2014 Feb 7;13(2):395-407. doi: 10.1021/pr400422g. Epub 2013 Dec 12. J Proteome Res. 2014. PMID: 24328148 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical